Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1980 1
1982 1
1983 1
1987 2
1988 4
1989 3
1990 4
1991 4
1992 2
1994 2
1995 3
1996 3
1997 4
1998 2
1999 6
2000 4
2001 2
2002 3
2003 3
2004 2
2005 6
2006 8
2007 4
2008 9
2009 8
2010 8
2011 15
2012 11
2013 16
2014 22
2015 23
2016 27
2017 30
2018 23
2019 27
2020 13
2021 13
2022 23
2023 25
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Results by year

Filters applied: . Clear all
Page 1
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Kjeldsen JW, Lorentzen CL, Martinenaite E, Ellebaek E, Donia M, Holmstroem RB, Klausen TW, Madsen CO, Ahmed SM, Weis-Banke SE, Holmström MO, Hendel HW, Ehrnrooth E, Zocca MB, Pedersen AW, Andersen MH, Svane IM. Kjeldsen JW, et al. Among authors: holmstrom mo. Nat Med. 2021 Dec;27(12):2212-2223. doi: 10.1038/s41591-021-01544-x. Epub 2021 Dec 9. Nat Med. 2021. PMID: 34887574 Free PMC article. Clinical Trial.
Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism.
Iglesias MJ, Sanchez-Rivera L, Ibrahim-Kosta M, Naudin C, Munsch G, Goumidi L, Farm M, Smith PM, Thibord F, Kral-Pointner JB, Hong MG, Suchon P, Germain M, Schrottmaier W, Dusart P, Boland A, Kotol D, Edfors F, Koprulu M, Pietzner M, Langenberg C, Damrauer SM, Johnson AD, Klarin DM, Smith NL, Smadja DM, Holmström M, Magnusson M, Silveira A, Uhlén M, Renné T, Martinez-Perez A, Emmerich J, Deleuze JF, Antovic J, Soria Fernandez JM, Assinger A, Schwenk JM, Souto Andres JC, Morange PE, Butler LM, Trégouët DA, Odeberg J. Iglesias MJ, et al. Among authors: holmstrom m. Nat Commun. 2023 Jun 7;14(1):3280. doi: 10.1038/s41467-023-38383-y. Nat Commun. 2023. PMID: 37286573 Free PMC article.
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, Christiansen AV, Friedman J, Le Maulf F, Peter N, Kearon C; RE-COVER II Trial Investigators. Schulman S, et al. Circulation. 2014 Feb 18;129(7):764-72. doi: 10.1161/CIRCULATIONAHA.113.004450. Epub 2013 Dec 16. Circulation. 2014. PMID: 24344086 Free article. Clinical Trial.
The Danish National Multiple Myeloma Registry.
Gimsing P, Holmström MO, Klausen TW, Andersen NF, Gregersen H, Pedersen RS, Plesner T, Pedersen PT, Frederiksen M, Frølund U, Helleberg C, Vangsted A, de Nully Brown P, Abildgaard N. Gimsing P, et al. Among authors: holmstrom mo. Clin Epidemiol. 2016 Oct 25;8:583-587. doi: 10.2147/CLEP.S99463. eCollection 2016. Clin Epidemiol. 2016. PMID: 27822103 Free PMC article. Review.
Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies.
Klausen U, Holmberg S, Holmström MO, Jørgensen NGD, Grauslund JH, Svane IM, Andersen MH. Klausen U, et al. Among authors: holmstrom mo. Front Immunol. 2018 Oct 1;9:2264. doi: 10.3389/fimmu.2018.02264. eCollection 2018. Front Immunol. 2018. PMID: 30327655 Free PMC article. Review.
Meniscal injury: II. Management.
Greis PE, Holmstrom MC, Bardana DD, Burks RT. Greis PE, et al. Among authors: holmstrom mc. J Am Acad Orthop Surg. 2002 May-Jun;10(3):177-87. doi: 10.5435/00124635-200205000-00004. J Am Acad Orthop Surg. 2002. PMID: 12041939 Review.
Cancer immune therapy for lymphoid malignancies: recent advances.
Klausen U, Jørgensen NGD, Grauslund JH, Holmström MO, Andersen MH. Klausen U, et al. Among authors: holmstrom mo. Semin Immunopathol. 2019 Jan;41(1):111-124. doi: 10.1007/s00281-018-0696-7. Epub 2018 Jul 13. Semin Immunopathol. 2019. PMID: 30006739 Review.
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.
Gigoux M, Holmström MO, Zappasodi R, Park JJ, Pourpe S, Bozkus CC, Mangarin LMB, Redmond D, Verma S, Schad S, George MM, Venkatesh D, Ghosh A, Hoyos D, Molvi Z, Kamaz B, Marneth AE, Duke W, Leventhal MJ, Jan M, Ho VT, Hobbs GS, Knudsen TA, Skov V, Kjær L, Larsen TS, Hansen DL, Lindsley RC, Hasselbalch H, Grauslund JH, Lisle TL, Met Ö, Wilkinson P, Greenbaum B, Sepulveda MA, Chan T, Rampal R, Andersen MH, Abdel-Wahab O, Bhardwaj N, Wolchok JD, Mullally A, Merghoub T. Gigoux M, et al. Among authors: holmstrom mo. Sci Transl Med. 2022 Jun 15;14(649):eaba4380. doi: 10.1126/scitranslmed.aba4380. Epub 2022 Jun 15. Sci Transl Med. 2022. PMID: 35704596
327 results